Growth through expansion Orthocell is actively expanding internationally, with recent activity in Hong Kong and Australia, signaling strong potential for partner distributors and clinical collaborations to accelerate Remplir™ adoption in new markets.

Nerve repair focus Remplir™ nerve wrap and its first surgical cases in major markets indicate a viable product for strategic sales targeting hospitals and surgeons specializing in peripheral nerve injuries and complex repair procedures.

Strategic leadership New Commercial Director appointed to drive distributor networks and commercialization in Australia and Asia, creating a clear channel for partner-led sales campaigns and regional market penetration.

Financial readiness Recent funding and robust cash reserves with no debt position Orthocell to fund market entry activities, training, and regional sales infrastructure without immediate financing constraints.

Clinical adoption momentum Launch events and early case completions at major orthopaedic congresses create credibility and opportunities for case-based selling, key opinion leader engagement, and hospital adoption programs.